$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
How much does a box of lorlatinib cost after medical insurance in 2021? How long can I take one box of Lorlatinib?
2025-10-19 11:44:20
Check Details
How effective is dacomitinib in treating brain metastases from lung cancer? Instructions for use of dacomitinib
2025-10-19 11:44:20
Check Details
How long does it take for resistance to lorlatinib to develop? How to treat lorlatinib resistance?
2025-10-19 11:44:20
Check Details
Will the price of lorlatinib be reduced in 2021? What is the price of lorlatinib after medical insurance in 2021?
2025-10-19 11:44:20
Check Details
Dacomitinib price in 2021, Dacomitinib latest medical insurance price in 2021
2025-10-19 11:44:20
Check Details
Has the lung cancer targeted drug dacomitinib been launched in the country? How long can patients with advanced lung cancer live on dacomitinib?
2025-10-19 11:44:20
Check Details
Is dacomitinib domestically produced or imported? How long does it take for dacomitinib to take effect?
2025-10-19 11:44:20
Check Details
How effective is dacomitinib in treating lung cancer? Usage and dosage of dacomitinib, a targeted drug for lung cancer
2025-10-19 11:44:20
Check Details
Drug instructions: What is the Chinese name of amg510?
2025-10-19 11:44:20
Check Details
Where can I buy the targeted drug AMG510 in the country?
2025-10-19 11:44:20
Check Details
What is the therapeutic effect of dacomitinib, a new first-line drug for EGFR mutated lung cancer
2025-10-19 11:44:20
Check Details
How much does a box of amg510 targeted drug cost? How to buy?
2025-10-19 11:44:20
Check Details
1
2
...
3937
3938
3939
3940
3941
3942
3943
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
2
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
3
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
4
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
5
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
6
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
7
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
8
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
9
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
10
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity
11
Tivozanib Dosing Guide for Renal Cell Carcinoma: 21-Day On/7-Day Off Cycle and Adjustments
12
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor